| P50 | author | Fernando Carmona | Q58575049 |
| | Alessandra Gianoncelli | Q43277715 |
| | Paolo Arosio | Q56446594 |
| P2093 | author name string | Mohamed Nejib Marzouki | |
| | Maura Poli | |
| | Michela Asperti | |
| | Mohamed Boumaiza | |
| | Paola Ruzzenenti | |
| | Michela Bertuzzi | |
| P2860 | cites work | LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity | Q24290410 |
| | Hepcidin, a urinary antimicrobial peptide synthesized in the liver | Q24290609 |
| | Hepcidin revisited, disulfide connectivity, dynamics, and structure | Q24651444 |
| | Tissue sulfhydryl groups | Q26778486 |
| | Mechanisms of mammalian iron homeostasis | Q27010510 |
| | Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation | Q28186993 |
| | Regulation of iron metabolism by hepcidin | Q28252744 |
| | Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells | Q28507904 |
| | Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin | Q28513640 |
| | Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies | Q30430925 |
| | Hepcidin targets ferroportin for degradation in hepatocytes | Q33707486 |
| | Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity | Q34362717 |
| | Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload | Q35578602 |
| | Expression and purification of a new recombinant camel hepcidin able to promote the degradation of the iron exporter ferroportin1. | Q35689860 |
| | The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study | Q35848479 |
| | Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans | Q35920651 |
| | Hepcidin: iron-hormone and anti-microbial peptide | Q36276140 |
| | Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. | Q36430612 |
| | Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli | Q36624644 |
| | Modulation of hepcidin to treat iron deregulation: potential clinical applications | Q36847852 |
| | Ferritins: a family of molecules for iron storage, antioxidation and more. | Q37301997 |
| | Iron regulatory proteins: from molecular mechanisms to drug development | Q37705384 |
| | Ferritin: a versatile building block for bionanotechnology. | Q38356225 |
| | Development of an immunoassay for all human isoferritins, and its application to serum ferritin evaluation | Q42102789 |
| | Molecular characterization of a novel hepcidin (HepcD) from Camelus dromedarius. Synthetic peptide forms exhibit antibacterial activity | Q42664129 |
| | Distinct stability of recombinant L and H subunits of human ferritin: calorimetric and ANS binding studies | Q47775539 |
| | Production of biologically active forms of recombinant hepcidin, the iron-regulatory hormone. | Q54420959 |
| | Recombinant ferritin: modulation of subunit stoichiometry in bacterial expression systems. | Q54560494 |
| P433 | issue | 2 | |
| P921 | main subject | Camelus | Q7375 |
| P304 | page(s) | 77-84 | |
| P577 | publication date | 2016-12-15 | |
| P1433 | published in | Protein Engineering Design and Selection | Q15762396 |
| P1476 | title | Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains | |
| P478 | volume | 30 | |